BHG:NYE-Bright Health Group Inc. (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 3.28

Change

-0.08 (-2.38)%

Market Cap

USD 2.10B

Volume

6.54M

Avg Analyst Target

USD 14.89 (+353.93%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Bright Health Group Inc. (BHG) Stock Analysis:
Based on the Bright Health Group Inc. stock forecasts from 9 analysts, the average analyst target price for Bright Health Group Inc. is USD 14.89 over the next 12 months. Bright Health Group Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bright Health Group Inc. is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Bright Health Group Inc.’s stock price was USD 3.28. Bright Health Group Inc.’s stock price has changed by -0.74 % over the past week, -4.33 % over the past month and +0.00 % over the last year.

About

Bright Health Group, Inc., an integrated care delivery company, engages in the delivery and financing of health insurance plans in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The company offers individual and family, Medicare, and employers i ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

+1.68 (+0.38%)

USD425.72B 27.58 17.95
CVS CVS Health Corporation

+1.21 (+1.36%)

USD121.47B 15.50 10.90
ANTM Anthem Inc

-4.91 (-1.21%)

USD101.02B 18.20 N/A
CI Cigna Corporation

+3.07 (+1.58%)

USD66.16B 8.10 N/A
HUM Humana Inc

+3.82 (+0.91%)

USD55.02B 20.36 N/A
CNC Centene Corporation

+1.24 (+1.77%)

USD41.67B 56.19 15.61
MOH Molina Healthcare Inc

+5.74 (+2.03%)

USD17.38B 28.12 12.11
GTS Triple-S Management Corporatio..

+0.14 (+0.40%)

USD0.85B 10.22 N/A

ETFs Containing BHG

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.10B 22% F 61% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.08 89% B+ 70% C-
Price / Cash Flow Ratio -36.66 100% A+ 94% A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -9,999,999.00% 11% F 0% N/A
Return on Invested Capital 64.78% 100% A+ 98% A+
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 4.21 11% F 24% F
Short Percent 2.78% 11% F 52% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector